Director/PDMR Shareholding

Summary by AI BETAClose X

Elementis PLC announced that its Chief Financial Officer, Kath Kearney-Croft, was granted 21,215 options under the Elementis PLC UK Savings-Related Share Option Scheme 2018 on September 15, 2026. These options are exercisable from November 1, 2031, at an option price of 144 pence per share, representing a total potential value of £30,556.80 based on the exercise price and volume.

Disclaimer*

Elementis PLC
16 September 2026
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

a)

Name

KATH KEARNEY-CROFT

2

Reason for the notification

a)

Position/status

CHIEF FINANCIAL OFFICER, DIRECTOR, PDMR

b)

Initial notification/Amendment

INITIAL NOTIFICATION

3

Details of the issuer, UK emission allowance market participant, auction platform or auctioneer

a)

Name

ELEMENTIS PLC

b)

LEI

549300LQIH685LI2ML36 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument;

(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

 

Identification code

SHARES

 

 

 

GB0002418548      

 

b)

Nature of the transaction

GRANT OF 21,215 OPTIONS UNDER THE ELEMENTIS PLC UK SAVINGS-RELATED SHARE OPTION SCHEME 2018.

 

THE OPTIONS ARE EXERCISABLE FROM 1 NOVEMBER 2031 WITH AN OPTION PRICE OF 144 PENCE PER SHARE. 

 

 

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£1.44

21,215

d)

Aggregated information

 

 

 


 

- Aggregated volume

- Price

 

N/A

e)

Date of the transaction

2026-09-15

f)

Place of the transaction

N/A

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Elementis (ELM)
UK 100

Latest directors dealings